NFE2L2 and Parkinson disease: Indeed, experiments in in vivo models of different neurodegenerative conditions such as PD [48,61], ALS [62], spinal cord injury [63], or vascular cognitive impairment [64] support the role of astrocytic Nrf2 in neuroprotection.